Department of Medical Oncology for Urologic Tumors
Peking University Cancer Hospital, Beijing
泌尿肿瘤内科 · Medical Oncology
This department specializes in the systemic medical treatment of urologic cancers, including kidney cancer, urothelial carcinoma, prostate cancer, adrenal tumors, and germ cell tumors. The team employs a multidisciplinary approach, collaborating with surgery, radiation therapy, interventional radiology, and nuclear medicine departments. Clinical care is integrated with teaching and research, focusing on tumor immunotherapy, drug resistance, anti-angiogenesis, and targeted gene therapy. The department participates in clinical trials for new drugs and contributes to national and international treatment guidelines. All staff physicians hold doctoral degrees, and the team maintains collaborations with multiple international cancer centers.
What the department treats
- Medical treatment for kidney cancer
- Treatment for urothelial carcinoma
- Care for prostate cancer
- Management of adrenal tumors and germ cell tumors
- Multidisciplinary team (MDT) consultations
- Clinical trials for new oncology drugs
Key facts
- The department handles over 30,000 outpatient visits and admits more than 8,000 patients annually.
- The medical team includes 10 physicians, all holding doctoral degrees, comprising 3 chief physicians and 3 associate chief physicians.
- Research funding exceeds 5 million yuan, supporting nearly 100 SCI publications.
As described by the hospital.
Team
9 doctors listed.
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion